Comprehensive Psychiatry
Volume 46, Issue 5 , Pages 315-321 , September 2005

A retrospective follow-up study of body dysmorphic disorder

References 

  1. Bienvenu OJ, Samuels JF, Riddle MA, Hoehn-Saric R, Liang KY, Cullen BAM, et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry. 2000;48:287–293
  2. Perugi G, Akiskal HS, Lattanzi L, Cecconi D, Mastrocinque C, Patronelli A, et al. The high prevalence of “soft” bipolar (II) features in atypical depression. Compr Psychiatry. 1998;39:63–71
  3. Phillips KA, McElroy SL, Keck PE, Pope HG, Hudson JI. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry. 1993;150:302–308
  4. Veale D, Boocock A, Gournay K, Dryden W, Shah F, Wilson R, et al. Body dysmorphic disorder: a survey of fifty cases. Br J Psychiatry. 1996;169:196–201
  5. DeMarco LM, Li LC, Phillips KA, McElroy SL. Perceived stress in body dysmorphic disorder. J Nerv Ment Dis. 1998;186:724–726
  6. Phillips KA. Quality of life for patients with body dysmorphic disorder. J Nerv Ment Dis. 2000;188:170–175
  7. Phillips KA, Menard W, Fay C, Pagano M. Psychosocial functioning and quality of life in body dysmorphic disorder. Compr Psychiatry. 2005;46:254–260
  8. Phillips KA. Body dysmorphic disorder: the distress of imagined ugliness. Am J Psychiatry. 1991;148:1138–1149
  9. Phillips KA, Diaz S. Gender differences in body dysmorphic disorder. J Nerv Ment Dis. 1997;185:570–577
  10. Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with BDD. Psychosomatics [in press].
  11. Veale D, Gournay K, Dryden W, Boocock A, Shah F, Willson R, et al. Body dysmorphic disorder: a cognitive behavioural model and pilot randomized controlled trial. Behav Res Ther. 1996;34:717–729
  12. Rosen JC, Reiter J, Orosan P. Cognitive-behavioral body image therapy for body dysmorphic disorder. J Consult Clin Psychol. 1995;63:263–269
  13. Wilhelm S, Otto MW, Lohr B, Deckersbach T. Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behav Res Ther. 1999;37:71–75
  14. Neziroglu F, Khemlani-Patel S. A review of cognitive and behavioral treatment for body dysmorphic disorder. CNS Spectr. 2002;7:464–471
  15. Phillips KA, Dwight MM, McElroy SL. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 1998;59:165–171
  16. Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry. 1999;56:1033–1039
  17. Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002;59:381–388
  18. Phillips KA. Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach. CNS Spectr. 2002;7:453–460
  19. McKay D. Two-year follow-up of behavioral treatment and maintenance for body dysmorphic disorder. Behav Modif. 1999;23:620–629
  20. Phillips KA, McElroy SL, Keck PE, Hudson JI, Pope HG. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull. 1994;30:179–186
  21. Reich JH, Vasile RG. Effect of personality disorders on the treatment outcome of axis I conditions: an update. J Nerv Ment Dis. 1993;181:475–484
  22. Coryell W, Leon A, Winokur G, Endicott J, Keller M, Akiskal H, et al. Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry. 1996;153:483–489
  23. Keller MB, Yonkers KA, Warshaw MG, Gollan J, Massion AO, White K, et al. Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up. J Nerv Ment Dis. 1994;182:290–296
  24. Warshaw MG, Keller MB, Stout RL. Reliability and validity of the longitudinal interval follow-up evaluation for assessing outcome of anxiety disorders. J Psychiatr Res. 1994;28:531–545
  25. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive-Compulsive Scale. Psychopharmacol Bull. 1997;33:17–22
  26. National Institute of Mental Health. Special feature: rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull. 1985;21:
  27. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766–771
  28. Diagnostic and statistical manual of mental disorders. 4th ed.. Washington (DC): American Psychiatric Association; 1994;
  29. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID): I. History, rationale, and description. Arch Gen Psychiatry. 1992;49:624–629
  30. Williams JBW, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, et al. The Structured Clinical Interview for DSM-III-R (SCID): II. Multisite test-retest reliability. Arch Gen Psychiatry. 1992;49:630–636
  31. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM III-R Personality Disorders (SCID-II) Part I: description. J Personal Disord. 1995;9:83–91
  32. First MB, Spitzer RL, Gibbon M, Williams JBW, Davies M, Borus J, et al. The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). Part II: multi-site test-retest reliability study. J Personal Disord. 1995;9:92–104
  33. Phillips KA, Atala KD, Pope HG. Diagnostic instruments for body dysmorphic disorder. In: New research program and abstracts, American Psychiatric Association 148th Annual Meeting. Miami. 1995;p. 157
  34. Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA. The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry. 1998;155:102–108
  35. Cox D, Oakes D. Analysis of survival data. New York: Chapman and Hall; 1984;
  36. Phillips KA, Nierenberg AA, Brendel G, Fava M. Prevalence and clinical features of body dysmorphic disorder in atypical major depression. J Nerv Ment Dis. 1996;184:125–129
  37. Phillips KA, Najjar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry. 2003;64:715–720
  38. Leon AC, Keller MB, Warshaw MG, Mueller TI, Solomon DA, Coryell W, et al. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects. Am J Psychiatry. 1999;156:195–201
  39. Warshaw MG, Keller MB. The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. J Clin Psychiatry. 1996;57:158–166
  40. Geerlings SW, Beekman AT, Deeg DJ, Twisk JW, Van Tilburg W. Duration and severity of depression predict mortality in older adults in the community. Psychol Med. 2002;32:609–618
  41. Steketee G, Eisen J, Dyck I, Warshaw M, Rasmussen S. Predictors of course in obsessive-compulsive disorder. Psychiatry Res. 1999;27:229–238
  42. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59:530–553
  43. Phillips KA, McElroy SL. Personality disorders and traits in patients with body dysmorphic disorder. Compr Psychiatry. 2000;41:229–236
  44. Hollander E, Cohen LJ, Simeon D. Body dysmorphic disorder. Psychiatr Ann. 1993;23:359–364
  45. Phillips KA, McElroy SL, Hudson JI, Pope HG. Body dysmorphic disorder: an obsessive compulsive spectrum disorder, a form of affective spectrum disorder, or both?. J Clin Psychiatry. 1995;56(S):41–52
  46. McElroy SL, Phillips KA, Keck PE. Obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1994;55(S):33–51
  47. Kasahara Y. Social phobia in Japan. In: Social phobia in Japan and Korea. Proceedings of the First Cultural Psychiatry Symposium Between Japan and Korea. Seoul, Korea: East Asia Academy of Cultural Psychiatry; 1987;

☆ This study was supported by a grant from the Department of Psychiatry and Human Behavior, Brown Medical School (Providence, RI) and by NIMH (Bethesda, MD) grant K24-MH63975 to Doctor Phillips.

PII: S0010-440X(04)00202-0

doi: 10.1016/j.comppsych.2004.12.001

Comprehensive Psychiatry
Volume 46, Issue 5 , Pages 315-321 , September 2005

Article Tools

* Image Usage & Resolution